Bavarian Nordic Announces that Janssen has completed a Submission for Emergency Use Assessment and Listing for its Ebola Vaccine Regimen to the World Health Organization
September 12, 2016 12:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Preparations also underway to initiate...
Bavarian Nordic meddeler at Janssen har indsendt ansøgning om nødberedskabsgodkendelse af ebolavaccinen til Verdenssundhedsorganisationen
September 12, 2016 12:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Desuden forbereder Janssen påbegyndelsen af...
Bavarian Nordic A/S - Vedtægter
August 31, 2016 07:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Opdaterede vedtægter for Bavarian Nordic A/S. ...
Bavarian Nordic A/S - Articles of Association
August 31, 2016 07:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Updated Articles of Association for...
Kapitalforhøjelse i Bavarian Nordic A/S som følge af medarbejderes udnyttelse af tegningsoptioner
August 31, 2016 05:15 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KØBENHAVN, Danmark, 31. august 2016 - Bavarian...
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
August 31, 2016 05:15 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COPENHAGEN, Denmark, August 31, 2016 -...
Bavarian Nordic offentliggør regnskab for første halvår 2016
August 17, 2016 01:52 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KØBENHAVN, Danmark, 17. august 2016 -...
Bavarian Nordic Announces First Half 2016 Results
August 17, 2016 01:52 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COPENHAGEN, Denmark, August 17, 2016 -...
Bavarian Nordic offentliggør aftale med Bristol-Myers Squibb om levering af lægemiddel til klinisk forsøg inden for lungekræft
August 15, 2016 07:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KØBENHAVN, Danmark, 15. august 2016 -...
Bavarian Nordic Announces Drug Supply Agreement with Bristol-Myers Squibb for NSCLC Clinical Study
August 15, 2016 07:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COPENHAGEN, Denmark, August 15, 2016...